GEN Exclusives

More »

GEN News Highlights

More »
Aug 6, 2007

J&JPRD to Apply Melior’s In Vivo Models

  • Melior Discovery’s theraTRACESM indications discovery platform will be used to identify possible new indications for multiple Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) drug candidates.

    The theraTRACE platform is a multiplexed set of integrated in vivo models that systematically test the potential efficacy of compounds across a large number of disease models. It reduces the time, amount of test compound, and number of test subjects needed while also reducing the number of false positive results, according to the companies.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?